AR241635A1 - Dispositivo osmotico para la administracion de una droga a regimen de liberacion dosificado. - Google Patents

Dispositivo osmotico para la administracion de una droga a regimen de liberacion dosificado.

Info

Publication number
AR241635A1
AR241635A1 AR88311836A AR31183688A AR241635A1 AR 241635 A1 AR241635 A1 AR 241635A1 AR 88311836 A AR88311836 A AR 88311836A AR 31183688 A AR31183688 A AR 31183688A AR 241635 A1 AR241635 A1 AR 241635A1
Authority
AR
Argentina
Prior art keywords
compartment
poly
composition
dosage form
ethylene oxide
Prior art date
Application number
AR88311836A
Other languages
English (en)
Spanish (es)
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of AR241635A1 publication Critical patent/AR241635A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AR88311836A 1988-06-02 1988-09-02 Dispositivo osmotico para la administracion de una droga a regimen de liberacion dosificado. AR241635A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/201,519 US4859470A (en) 1988-06-02 1988-06-02 Dosage form for delivering diltiazem

Publications (1)

Publication Number Publication Date
AR241635A1 true AR241635A1 (es) 1992-10-30

Family

ID=22746162

Family Applications (1)

Application Number Title Priority Date Filing Date
AR88311836A AR241635A1 (es) 1988-06-02 1988-09-02 Dispositivo osmotico para la administracion de una droga a regimen de liberacion dosificado.

Country Status (25)

Country Link
US (1) US4859470A (en:Method)
JP (1) JP2590226B2 (en:Method)
KR (1) KR960006062B1 (en:Method)
AR (1) AR241635A1 (en:Method)
AT (1) AT394311B (en:Method)
AU (1) AU612398B2 (en:Method)
BE (1) BE1001935A3 (en:Method)
CA (1) CA1311687C (en:Method)
CH (1) CH675208A5 (en:Method)
DE (1) DE3829941C2 (en:Method)
DK (1) DK175396B1 (en:Method)
ES (1) ES2008813A6 (en:Method)
FI (1) FI92553C (en:Method)
FR (1) FR2632306B1 (en:Method)
GB (1) GB2219205B (en:Method)
GR (1) GR1000197B (en:Method)
IE (1) IE61861B1 (en:Method)
IT (1) IT1223799B (en:Method)
LU (1) LU87327A1 (en:Method)
MX (1) MX174157B (en:Method)
NL (1) NL194747C (en:Method)
NO (1) NO174766C (en:Method)
PT (1) PT88405B (en:Method)
SE (1) SE503508C2 (en:Method)
ZA (1) ZA886436B (en:Method)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
US5112614A (en) * 1989-09-14 1992-05-12 Alza Corporation Implantable delivery dispenser
US5208037A (en) * 1991-04-22 1993-05-04 Alza Corporation Dosage forms comprising polymers comprising different molecular weights
US6283951B1 (en) * 1996-10-11 2001-09-04 Transvascular, Inc. Systems and methods for delivering drugs to selected locations within the body
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
US6562375B1 (en) 1999-08-04 2003-05-13 Yamanouchi Pharmaceuticals, Co., Ltd. Stable pharmaceutical composition for oral use
ES2262528T3 (es) * 1999-08-04 2006-12-01 Astellas Pharma Inc. Composiciones medicinales estables para administracion oral que utilizan oxidos de hierro.
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
US6753011B2 (en) 2000-01-14 2004-06-22 Osmotica Corp Combined diffusion/osmotic pumping drug delivery system
US6352721B1 (en) * 2000-01-14 2002-03-05 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system
PE20040134A1 (es) * 2002-07-25 2004-03-06 Pharmacia Corp Forma de dosificacion de una vez al dia de pramipexol
MX2007001850A (es) 2004-08-13 2007-03-28 Boehringer Ingelheim Int Formulacion de pildora de liberacion prolongada que contiene pramipexol o una sal farmaceuticamente aceptable del mismo, metodo para fabricarlo y uso del mismo.
JP4757872B2 (ja) 2004-08-13 2011-08-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング プラミペキソール又はその医薬品として許容される塩を含む放出が延長された錠剤調合物、その製造方法及びその使用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4063064A (en) * 1976-02-23 1977-12-13 Coherent Radiation Apparatus for tracking moving workpiece by a laser beam
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4285987A (en) * 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US4235236A (en) * 1979-02-12 1980-11-25 Alza Corporation Device for dispensing drug by combined diffusional and osmotic operations
IT1153487B (it) * 1982-04-15 1987-01-14 Prophin Lab Spa Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
IT1206166B (it) * 1984-07-26 1989-04-14 Sigma Tau Ind Farmaceuti Dispositivo per rilasciare una sostanza in un fluido di dissoluzione con cinetica di ordine zero e procedimento per la sua preparazione
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
EP0205336B1 (en) * 1985-06-11 1991-09-11 Teijin Limited Oral sustained release pharmaceutical preparation
US4753802A (en) * 1986-03-19 1988-06-28 Alza Corporation Verapamil dosage form
ATE75394T1 (de) * 1986-11-14 1992-05-15 Ciba Geigy Ag Orales osmotisches system fuer metoprolol mit verbesserten formulierungseigenschaften.

Also Published As

Publication number Publication date
GB2219205A (en) 1989-12-06
ES2008813A6 (es) 1989-08-01
CA1311687C (en) 1992-12-22
SE503508C2 (sv) 1996-06-24
NO174766B (no) 1994-03-28
LU87327A1 (fr) 1989-03-08
GB8820461D0 (en) 1988-09-28
DE3829941C2 (de) 1997-07-03
AT394311B (de) 1992-03-10
ZA886436B (en) 1989-05-30
FR2632306A1 (fr) 1989-12-08
NO883838D0 (no) 1988-08-29
MX174157B (es) 1994-04-25
JPH01313432A (ja) 1989-12-18
DK485688A (da) 1989-12-03
IE61861B1 (en) 1994-11-30
IE882642L (en) 1989-12-02
US4859470A (en) 1989-08-22
PT88405B (pt) 1995-07-18
NL194747B (nl) 2002-10-01
FR2632306B1 (fr) 1990-11-16
KR960006062B1 (ko) 1996-05-08
SE8803085L (sv) 1989-12-03
FI884057A0 (fi) 1988-09-02
NO883838L (no) 1989-12-04
BE1001935A3 (fr) 1990-04-17
IT8867791A0 (it) 1988-09-02
DE3829941A1 (de) 1989-12-14
NL8802181A (nl) 1990-01-02
IT1223799B (it) 1990-09-29
AU2152788A (en) 1989-12-07
GR880100574A (en) 1990-05-11
GR1000197B (el) 1992-03-20
JP2590226B2 (ja) 1997-03-12
FI92553C (fi) 1994-12-12
DK175396B1 (da) 2004-09-27
ATA214588A (de) 1991-09-15
GB2219205B (en) 1992-07-15
FI884057L (fi) 1989-12-03
AU612398B2 (en) 1991-07-11
NO174766C (no) 1994-07-06
DK485688D0 (da) 1988-09-01
FI92553B (fi) 1994-08-31
CH675208A5 (en:Method) 1990-09-14
PT88405A (pt) 1990-06-29
NL194747C (nl) 2003-02-04
KR900000076A (ko) 1990-01-30
SE8803085D0 (sv) 1988-09-02

Similar Documents

Publication Publication Date Title
AR241635A1 (es) Dispositivo osmotico para la administracion de una droga a regimen de liberacion dosificado.
MX167175B (es) Sistema de entrega de drogas, con liberacion controlada, para la bolsa periodontal
MX173300B (es) Mejoras en forma de dosis para suministrar droga al intestino
ES2050363T3 (es) Sistema para la liberacion intraoral de medicamento.
MX169706B (es) Dispositivo de administracion prolongada que incluye dosis de carga
SE7613035L (sv) Osmotiskt driven avgivningsanordning med en av kompositmaterial bestaende vegg
ES2087281T3 (es) Sistema de produccion de fluidos de dialisis con pildora de dialisis.
ES2058081T3 (es) Poliesteres que contienen bloques de oxido de alquileno como sistemas de administracion de medicamentos.
MX9203556A (es) Una forma de dosificacion para administrar los farmacos beneficos pseudoefedrina y bromofeniramina.
CU22838A3 (es) Composiciones para controlar colonización bacteriana
AR041562A1 (es) Preparacion de liberacion controlada
ES2051881T3 (es) Procedimiento de preparacion de un formulacion farmaceutica de liberacion prolongada.
PT1140012E (pt) Conversao de capsulas de gelatina cheias com liquido em sistemas de libertacao controlada por camadas multiplas
CU22768A3 (es) Sistema, dispositivo y dosis unitaria para el suministro y empaque de medicamento
BR0009609A (pt) Formas de dosagem de rápida dispersão contendo gelatina de peixe
ES2039758T3 (es) Septum para dispositivos susceptibles de ser implantados para la administracion de sustancias.
PE39599A1 (es) Dispositivo de inhalacion
ES2193193T3 (es) Inhalador de polvo.
MX9303879A (es) Uso beneficio de desperdicios que contienen energia.
ES2059495T3 (es) Dispositivo de descarga de farmacos regulado por solubilidad.
MX9203557A (es) Una forma de dosis para suministrar el farmaco benefico verapamil.
MX9305965A (es) Dispositivos de suministro de agente activo, con efecto pulsatil altamente controlable.
ES357656A1 (es) Perfeccionamientos en la construccion de aparatos para lle-nar agujeros perforados con una masa pastosa o plastica.
ES2062043T3 (es) Formulaciones topicas y sistemas de suministro transdermico que contienen 1-isobutil-1h-imidazo(4,5-c)-quinolein-4-amina.
PE3096A1 (es) Formulacion conteniendo selenio